AVITHRAPID
banner
avithrapid.bsky.social
AVITHRAPID
@avithrapid.bsky.social
The EU-funded project AVITHRAPID aims to develop broad spectrum antiviral therapeutics for infectious diseases with epidemic – and subsequently pandemic – potential.
14 Jan - #WorldLogicDay
Logic drives AI, modelling and antiviral discovery.
At #AVITHRAPID, it powers prediction, screening and preparedness.
Strong science = strong reasoning.
#Science #HorizonEurope
January 14, 2026 at 11:52 AM
What does “pandemic preparedness” actually mean?

It’s more than emergency response.
Preparedness happens before a crisis - through research, coordination, and systems designed to act fast when needed.

It’s an ongoing process, not a single moment.
#PandemicPreparedness #GlobalHealth
January 7, 2026 at 7:58 AM
2025 was a key year for #AVITHRAPID 🚀
From strengthening European collaborations to advancing antiviral research and knowledge sharing, we worked together to improve #pandemicpreparedness and #globalhealth resilience.

Thank you to all partners - onward to 2026!
December 23, 2025 at 2:17 PM
Universal Health Coverage Day.
Preparedness is part of universal health.

AVITHRAPID contributes by advancing antiviral research and strengthening future response capacities.

#AVITHRAPID #GlobalHealth
December 12, 2025 at 11:57 AM
Epidemic = local surge.
Pandemic = global spread.

Severity isn’t what defines a pandemic - reach does.
COVID-19 proved how fast that jump can happen.

#AVITHRAPID #Preparedness
December 9, 2025 at 1:45 PM
At SC25 (Nov 2025, St. Louis), @it4innovations.bsky.social showcased AVITHRAPID - highlighting how high-performance computing fuels the next generation of antiviral research.
Thank you, IT4Innovations!
#AVITHRAPID #SC25 #HPC #Research
December 3, 2025 at 8:27 AM
🌐 AVITHRAPID Project Portal - your gateway to antiviral R&D and pandemic preparedness.

🔗 Discover more: avithrapid.eu/projec...

#AVITHRAPID #InnovationGateway #AntiviralResearch #Preparedness"
November 20, 2025 at 7:03 AM
AVITHRAPID evolves! 🧬
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery
November 12, 2025 at 8:35 AM
Small molecules are a flexible and scalable tool for new and resistant viruses.

AVITHRAPID puts them at the core of our antiviral strategy.

#Antivirals #Innovation #AVITHRAPID
November 4, 2025 at 12:11 PM
20th October AVITHRAPID hosted a seminar with the APPEAL project, fostering an inspiring exchange of ideas within the #HorizonEU framework.
October 23, 2025 at 2:24 PM
Today is Global Handwashing Day.

Hand hygiene prevents infections, yet the development of antivirals and small molecules is essential to tackle emerging viruses and safeguard public health.
#GlobalHandwashingDay #HealthInnovation #DrugDiscovery #Science
October 15, 2025 at 12:18 PM
Small molecules are key to the future of antivirals: fast to develop, easy to deliver, globally accessible.

At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.

#AVITHRAPID #Antivirals #DrugDiscovery
October 9, 2025 at 7:02 AM
AVITHRAPID will be at the European Researchers’ Night on 26 Sept in Italy 🇮🇹.
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation
September 23, 2025 at 3:29 PM
AVITHRAPID will be part of Settimana della Scienza in Italy (20–27 Sept) 🇮🇹 through our partner Tor Vergata University.
At their stand, you can learn more about our mission and the future of antiviral drug discovery.

Program: www.frascatiscienza....

#AVITHRAPID #ScienceWeek #ERN2025
September 18, 2025 at 7:38 AM
AVITHRAPID is advancing broad-spectrum antivirals across Europe — and we’re sharing it with you.

Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth
August 27, 2025 at 4:39 PM
Broad-spectrum antivirals (BSAs) target host or conserved viral parts, working across virus families. They deploy fast and aid pandemic prep without needing virus ID. Trade-offs: toxicity, resistance risk, less precision. Still, BSAs could be key for unpredictable outbreaks. #HealthTech #Science
August 19, 2025 at 3:32 PM
It’s #WorldBreastfeedingWeek - a reminder that science must reflect everyone’s needs.
At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact.
#ScienceFeed #HealthEquity
August 13, 2025 at 11:43 AM
Who’s behind AVITHRAPID?
A Europe-wide network of labs, hospitals, and research centres working together on broad-spectrum antivirals.
August 5, 2025 at 12:39 PM
From hepatitis C to tomorrow’s viruses: AVITHRAPID builds on proven science to prepare for future outbreaks.

#WorldHepatitisDay #ScienceFeed
July 28, 2025 at 10:31 AM
AVITHRAPID has signed an MoU with @AREASciencePark to strengthen Europe’s preparedness for future pandemics.
The partnership will boost rapid antiviral development, training, funding strategy & long-term impact.

#AVITHRAPID #ScienceFeed #PandemicResponse
July 25, 2025 at 5:04 PM
What’s next for AVITHRAPID?
Following our meeting in Berlin , we’re entering a critical phase — improving existing antivirals while evaluating new broad-spectrum compounds.
Stronger preparedness through innovation.

#AVITHRAPID #PandemicPreparedness #OneHealth
July 18, 2025 at 6:58 PM
🧪 Last 16-17 June, the #AVITHRAPID team met in Berlin to plan next steps in antiviral preparedness! Great science, strong collaboration — and a few laughs too 😄
📸 Highlights below!
#HorizonEU #DrugRepurposing #PandemicPreparedness
July 10, 2025 at 6:13 AM
Neglected tropical diseases (NTDs) affect over 1.5 billion people worldwide, yet treatment options remain limited. Broad-spectrum antivirals offer a promising solution. Let’s push for innovation and progress. Stay informed on the latest updates—subscribe to our newsletter at www.avithrapid.eu
June 12, 2025 at 6:30 AM
Our consortium partners are meeting next week in Berlin for an exciting session to exchange ideas, review progress, and plan upcoming work. Are you part of a team focused on antiviral development? Reach out to explore future collaborations with us! #AVITHRAPID #Collaboration #Innovation
June 11, 2025 at 6:30 AM
Market gaps in broad-spectrum #antivirals are clear: limited #discovery platforms, resistance concerns, clinical trial barriers, and access issues. It’s time to bridge these gaps and innovate to protect global health. Subscribe to our newsletter: www.avithrapid.eu
June 10, 2025 at 6:30 AM